Outbreak of Crimean-Congo Hemorrhagic Fever Reported in North Macedonia
In a recent report by the World Organisation for Animal Health (WOAH), North Macedonia has witnessed an outbreak of Crimean-Congo Hemorrhagic Fever (CCHF). The country's veterinary authority notified WOAH about the occurrence, raising concerns about the spread of this highly infectious disease. This article provides an overview of the outbreak and its potential implications.
According to the WOAH report, the outbreak was confirmed on September 5, 2023, in the Karbinci region of North Macedonia. The transmission of the disease is suspected to have occurred through an intermediate host. Laboratory tests identified 17 suspected cases of infection among a mixed group of sheep and goats, with 10 fatalities.
The North Macedonian veterinary authority promptly responded to the outbreak, implementing control measures to contain the spread of CCHF. As of the report's publication, the outbreak has been successfully contained, and no further cases have been reported. The veterinary authority will no longer submit any additional reports on the matter.
Crimean-Congo Hemorrhagic Fever is a viral disease that primarily affects animals, especially livestock, but it can also be transmitted to humans through tick bites or contact with infected animal blood or tissues. The disease can result in severe hemorrhagic symptoms and has a high fatality rate.
The identification and swift response to the outbreak in North Macedonia highlight the importance of effective surveillance systems and rapid containment measures. The collaboration between veterinary authorities and international organizations like WOAH plays a crucial role in monitoring and managing such outbreaks to prevent further spread and protect public health.
The outbreak of Crimean-Congo Hemorrhagic Fever in North Macedonia serves as a reminder of the constant threat posed by infectious diseases. Prompt detection, reporting, and implementation of control measures are essential in preventing the spread of such diseases. Continued vigilance, international collaboration, and public awareness are critical in safeguarding both animal and human health against emerging infectious diseases.
Disclaimer: This article is a summary and interpretation of the information provided in the original source. For accurate and up-to-date information, it is recommended to refer to official reports and statements from relevant authorities.
Looking for chemical products? Let suppliers reach out to you!
2026-06-28
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Reducing to Refocus: Novo Nordisk’s 9,000-Job Cut and the Strategic Realignment in Pharma
-
U.S. API Dependence Turns Pharmaceutical Ingredients Into a National Security Issue
-
Pharma Tariff Risk Pushes Global Drugmakers to Rebuild U.S. Supply Chains
-
Roche Takes Natco to Supreme Court Over Generic Risdiplam Launch in India
-
India Accuses Balaji Amines of Manufacturing Pharma-Grade Propylene Glycol Without Drug Manufacturing Licence
-
J&J to Spin Off Orthopedics Business, Raises 2025 Forecast
-
Bayer’s Ambitious Gene & Cell Therapy Pipeline Eyes Parkinson’s, Oncology, Rare Diseases
-
Aspen Secures Approval to Market Lilly’s Mounjaro for Weight Loss in South Africa
-
Bristol Myers Squibb Launches Mavacamten (“Kopozgo”) in India for Obstructive Hypertrophic Cardiomyopathy
-
FDA Fee Updates Raise the Cost of Entering the U.S. Generic Drug Chain
Recommend Reading
-
After Semaglutide Patent Expiry in India, the Price System Has Been Restructured as More Than 40 Drugmakers Enter the Competition
-
NHU and Sinopec Advance Liquid Methionine Project
-
Novo Nordisk Reports Theft of Six Drug Batches in India Authorities Warn of Severe Patient Safety Risks
-
Parliamentary Panel Urges Expanded Price Controls as Dozens of Cancer Drugs Remain Unregulated
-
Glenmark Recalls Over 110000 Bottles of BP and COPD Drugs in US Due to Safety Concerns
-
Increased Supply Leads to Volatile Decline in Isooctanol Prices This Week
-
Weak Demand Leads to Decline in Urea Market Prices in China (9.8-9.15)
-
Ammonium Sulfate Market Optimistic in 2025, Exports Remain Core Growth Driver in 2026
-
Cost Increase Leads to Slight Recovery in Phthalic Anhydride Prices
-
Supply Benefits Fade, Melamine Market Stabilizes After the Holiday in China